eMedicine Specialties > Ophthalmology > Cornea

Corneal Erosion, Recurrent

Author: Arun Verma, MD, Senior Consultant, Department of Ophthalmology, Dr Daljit Singh Eye Hospital, India
Coauthor(s): Michael P Ehrenhaus, MD, Director, Department of Cornea, External Disease & Refractive Surgery, Assistant Professor, Department of Ophthalmology, State University of New York Downstate Medical Center
Contributor Information and Disclosures

Updated: Jun 17, 2009

Introduction

Background

Recurrent corneal erosion (RCE) syndrome is a condition that is characterized by a disturbance at the level of the corneal epithelial basement membrane, resulting in defective adhesions and recurrent breakdowns of the epithelium.

Recurrent corneal erosion.

Recurrent corneal erosion.

Recurrent corneal erosion.

Recurrent corneal erosion.


RCE syndrome may occur secondary to corneal injury or spontaneously. In the latter case, some predisposing factor, such as diabetes or a corneal dystrophy, may be the underlying cause. Management of RCE syndrome is usually aimed at regenerating or repairing the epithelial basement membrane to restore the adhesion between the epithelium and the anterior stroma.

Corneal erosions are perhaps one of the most common and neglected ocular disorders. Some of these cases occur after ocular trauma, but most of them occur spontaneously. Painful RCE syndrome, whether due to trauma or to anterior basement membrane dystrophy (Cogan dystrophy or map-dot-fingerprint dystrophy), results from abnormalities in the epithelial basement membrane.

Map-dot-fingerprint dystrophy.

Map-dot-fingerprint dystrophy.

Map-dot-fingerprint dystrophy.

Map-dot-fingerprint dystrophy.



Manifestation

Recurrent corneal erosions and epithelial basement membrane dystrophy are usually bilateral and are characterized by various patterns of dots, parallel lines that mimic fingerprints, and patterns that resemble maps, which appear in the epithelium. Individual microcysts may be oval, oblong, or comma-shaped and rarely appear alone but usually are associated with map and fingerprint patterns. On the other hand, the map and fingerprint patterns appear without dots or individual microcysts.

Map and fingerprint alterations of the corneal epithelium are not rare and can be found in asymptomatic individuals without prior history of trauma or ocular disease. Literature suggests that these epithelial changes are more common than previously recognized. They frequently are seen in conditions involving corneal edema, such as near a healing cataract surgery incision, or in the center of the cornea associated with Fuchs corneal dystrophy.

Clinical manifestations of Fuchs dystrophy

Three stages of Fuchs endothelial dystrophy are recognized. The 3 stages usually evolve gradually over a period of 25 years, and, like other corneal dystrophies, they usually are bilateral but asymmetric.

The first stage is the onset of cornea guttata, usually in the fourth decade of life. Subjective symptoms rarely occur until the fifth or sixth decade. During the asymptomatic phase, endothelial guttata and pigment dusting can be seen by slit lamp examination of the central corneal endothelium and by specular reflection. The guttate excrescences can become more numerous and confluent so that individual guttata are lost completely in the beaten-metal appearance of the endothelial surface. The central cornea is involved first, and, as the disease progresses, it spreads toward the periphery.

In the second phase of the disease, blurred vision, glare, and halos around lights develop because of incipient corneal edema in the stroma and epithelium. Epithelial edema can be seen as small droplets (bedewing) on retroillumination with the slit lamp. Epithelial microcysts coalesce to form bullae, which produce varying amounts of pain when they burst; hence, the name bullous keratopathy. Striae form in the Descemet membrane as the cornea thickens posteriorly due to stromal swelling. The arc of the Descemet membrane from limbus to limbus is shortened, causing wrinkles in the Descemet membrane called striae. The microcystic epithelial vesicles may break, causing foreign body sensations and severe pain with more extensive corneal epithelial disruption.

In the third stage, recurrent corneal erosions, microbial ulceration, and persistent pain may occur. Corneal sensitivity usually is reduced.

Pathophysiology

The 2 categories of corneal abrasions are as follows: superficial (those not involving the Bowman layer) and deep (those that penetrate the Bowman layer but do not rupture the Descemet membrane). Corneal abrasions may result from foreign bodies, contact lenses, chemicals, fingernails, hair brushes, tree branches, and dust.


Corneal abrasion.

Corneal abrasion.

Corneal abrasion.

Corneal abrasion.


The cornea has remarkable healing properties. The epithelium adjacent to any insult expands in size to fill in the defect, usually within 24-48 hours. Lesions that are purely epithelial often heal quickly and completely without scarring. Lesions that extend below the Bowman layer are more likely to leave a permanent scar.

The epithelial healing process begins when basal epithelial cells undergo mitosis, producing new cells that occupy fresh wounds. Basal cells adhere the epithelium to the stroma in 2 ways: they secrete the basement membrane, and they contain hemidesmosomes, which are essentially linchpins that protrude through the posterior surface of basal cells and into the stroma; each is held in place by an anchoring fibril. Any disruption to basal cell production makes the eye more prone to recurrent erosion.

Recurrent corneal erosions occur because there is a defect in the epithelial basement membrane and in hemidesmosomes formation, resulting in epithelial loss, microcysts, and bullae.

Recurrent corneal erosions occurring after injury or any corneal insult result because of improper or inadequate healing of the basement membrane, either because the basal epithelial cells fail to produce proper basement membrane complexes to attach to the Bowman layer and stroma or because of faulty basement membrane adherence.

A traumatic cause has a better eventual prognosis for full recovery than does the spontaneous form. In the case of spontaneous corneal erosions, the underlying disease process may be an epithelial basement membrane corneal dystrophy. Studies with the electron microscope have shown that during recurrent corneal erosion episodes, there is separation of the anchoring system at the level of the epithelial cell membrane or below the level of the anchoring plaques. Normal and degenerate polymorphonuclear leucocytes (PMNs) were found within and between the epithelial cells and within the anchoring layer. The degenerate PMNs may secrete metalloproteinases that cleave the Bowman layer below the anchoring system.

Frequency

United States

Recurrent corneal erosions are quite frequent in developing countries where lack of proper nutrition plays a significant role in the health of the cornea. Moreover, they are more frequent in patients with the predisposing factors and in those patients that have associated skin problems (see Causes).

Mortality/Morbidity

The tendency for epithelial basement membrane dystrophy, recurrent erosion, or both is probably hereditary, with variable penetrance. If corneal erosions are inherited, the pattern is dominant; however, most corneal erosions are acquired. In a study by Laibson, it has been found that 6% of the patients treated for a variety of other ocular conditions and diseases also demonstrated map, dot, and fingerprint changes in the epithelium.1

A recurrent corneal erosion is most likely to develop in a person who has had a previous corneal abrasion that was very sharp, clean, and linear, like that from a paper cut. Because the cut is so sharp, without ragged edges, it is less likely to stick down tightly to the underlying basement membrane. Those who have an abnormal structure to the corneal epithelium (called map-dot-fingerprint dystrophy) are at a much greater risk of poor healing following a corneal abrasion and, thus, can develop a recurrent corneal erosion.

Just as it is nearly impossible to see a corneal abrasion with the naked eye, the same is true for a recurrent corneal erosion. The time course is most important. In a recurrent corneal erosion, the patient can remember having had a corneal abrasion relatively recently (usually within the past 3–10 d) and then most often when first opening the eye in the morning.

Sex

Recurrent corneal erosions usually are seen as a bilateral problem occurring somewhat more frequently in females than in males. The epithelium may show a slipped-rug appearance; filaments are often seen. The recurrent erosions may occur over multiple sites on the cornea, a situation different from traumatic erosions.

Age

Recurrent corneal erosions and epithelial basement membrane dystrophy occur in adults, usually after the fourth decade of life. However, there are studies that have associated recurrent corneal erosions with juvenile Alport syndrome, which is an X-linked condition that also presents with anterior lenticonus and retinal flecks, as well as renal complications. Certain anterior corneal dystrophies, such as Reis-Bücklers, and lattice dystrophies can cause painful recurrent erosions in children.

Clinical

History

For all patients who present with signs and symptoms of RCE syndrome, a careful history and examination of the cornea should be undertaken to ensure that no underlying factors have predisposed these patients to this condition. This applies even in those cases where a history of injury to the cornea is present because a defect in the epithelial basement membrane complex may have been present before the initial trauma.

Of patients with anterior basement membrane dystrophy, 80-90% are asymptomatic. The primary symptom of recurrent erosion syndrome is mild to severe eye pain. Symptoms, when they occur, consist of one or more of the following:

  • Slightly blurred vision (when the epithelial and basement changes are in the visual axis)
  • Visual acuity loss
  • Astigmatism
  • Epithelial blebs
  • Foreign body sensation with recurrent erosion, when the epithelium loosens  
    • This is commonly the first symptom of recurrent erosion, and, in some cases, patients who have previously experienced this pain on awakening are so fearful of the pain that they are unable to sleep well.
    • The pain is fleeting in most cases, lasting only for a few seconds, but it may last from minutes to 1-2 hours and is a warning that the epithelium has not healed.
    • Attacks of pain and ocular irritation occurring in the early morning hours or upon awakening are understandable because corneal hydration from lid closure may be a factor affecting epithelial adhesion. An abnormal adherence between lid and cornea may be a factor in setting the stage for an attack of epithelial erosion.
    • Sudden sharp pain often is felt in the early morning during sleep or on awakening when a frank epithelial defect occurs because of the eyelid movement across the loosened epithelium.
  • Recurrences affect the area of the cornea that was previously injured.

Physical

Depending on the severity of the erosion, corneal examination findings may be totally normal, or they may reveal telltale signs of RCE syndrome. A classic history of recurrent pain upon awakening is often more important than seeing classic signs of corneal irregularity in making the correct diagnosis of RCE syndrome.

  • During an acute attack, one may see epithelial loss, epithelial microcysts, bullae, lack of adherence of sheets of epithelium, and epithelial filament formation. In these instances, the visual acuity may be impaired severely if the pathogenic condition occurs in the pupillary area. The examination findings may be totally normal, or there may be barely visible epithelial irregularities (may have negative staining) where the erosion has almost completely resolved.
  • An external eye examination generally shows a corneal abrasion, often centrally located that stains brightly with fluorescein. The abraded area tends to create loose edges with moderate-to-large epithelial flaps, which commonly form. A brownish granular edema (brawny edema) may occupy the underlying anterior stroma. The tendency toward a central location and dense secondary edema can cause a significant deterioration in vision.
  • Recurrent corneal erosions can be classified as either microform or macroform. With the latter, severe pain persists from hours to days as a result of a large area of the epithelium being separated from the cornea. In posttraumatic cases, the microform type of erosion always occurs at the site of the original abrasion. Microform recurrent erosions are characterized by intraepithelial microcysts with a minor break in the epithelium. These erosions are usually associated with brief episodes of pain, lasting from seconds to minutes.
  • Laibson et al have stated that in the interval between attacks, one can detect epithelial cysts, surface irregularity, and some subepithelial scarring on slit lamp examination.1 The healed epithelial area may even resemble a dendritic figure, a pseudodendrite. This fact should be kept in mind to avoid prescribing unnecessary medication.

Causes

The corneal epithelial basement membrane complex is responsible for the tight adhesion of the epithelial basal cell layer to the underlying stroma. The primary abnormality with RCE syndrome is poor adhesion of the epithelium to the Bowman layer due to a failure to establish or maintain normal adhesion complexes. Multiple recurrences are common because the basal epithelial cells require at least 8-12 weeks to regenerate or repair the epithelial basement membrane.

Most cases of recurrent erosions are related to anterior basement membrane dystrophy or are caused by corneal injuries from fingernails and paper. Acquired recurrent erosions also are observed after the following:

  • Alkali burns
  • Foreign bodies
  • Post infectious ulcers from herpes simplex
  • Exposure
  • Cockayne syndrome
  • Reis-Bücklers dystrophy
  • Vitrectomy
  • Photocoagulation
  • Secondary to other corneal dystrophies (eg, lattice, Fuchs, other anterior membrane dystrophies)
  • Contact lenses  
    • Soft contact lenses have many uses and are made from a variety of materials. The most common pitfall in the matter of lens care is the inability to keep lenses clean of deposits. These deposits can consist of protein, lipid, or calcium. They can cause discomfort, pseudomyopia, loss of vision, displacement of lenses (usually in an upward direction), and corneal erosions.
    • Unfortunately, thimerosal (sodium ethylmercurithiosalicylate) is the major offender in producing a delayed hypersensitivity response. It causes recurrent corneal erosions, conjunctival hyperemia, or corneal deposits. Many thimerosal-free solutions are now being prepared.
    • Drying of the lenses can result in a change in lens curvature, which alters the fit and can cause conjunctival irritation and swelling or corneal epithelial erosions. Conjunctival swelling results in tightening of the lens, which can cause pain, corneal edema, and epithelial erosions.
    • A flat-fitting contact lens moves too much and is uncomfortable to wear. Such a lens can give rise to central corneal epithelial edema and erosions. If the lens is too tight, the eye becomes uncomfortable, there is circumcorneal injection, and there may be epithelial erosions.
    • Postoperative management of corneal transplants for severely alkali-burned corneas includes the protection of the epithelium with well-fitted bandage contact lenses. But if the lenses are not of proper fit, they can lead to recurrent corneal erosions.
    • Recurrent corneal erosion is an indication for the use of a therapeutic lens. However, with the advent of anterior stromal puncture and related procedures, many clinicians choose to definitively treat typical posttraumatic recurrent corneal erosions, thereby minimizing the number of such patients requiring therapeutic lenses. Bandage lens treatment, if used for this indication, must be continued for up to 8-26 weeks to facilitate repair of the corneal epithelial basement membrane.
  • Patients with junctional epidermolysis bullosa, one of the rarest types, have more corneal problems (eg, recurrent corneal erosions) but relatively little conjunctival involvement. 
    • In the acquired autoimmune form, the immune response is believed to be directed against the basement membrane proteins uncein and collagen VII. It may be associated with small subepithelial vesicles in the cornea, symblepharon, and scarring of the lacrimal puncta.
    • Topical neomycin produces contact hypersensitivity in 5-10% of patients. Eyelid edema, conjunctivitis, and punctate corneal erosions may be due to allergic and toxic effects of topical neomycin.
    • While the corneal epithelium is affected minimally by a low dose of topical neomycin, cytotoxicity occurs at concentrations greater than 5 mg/mL. Corneal sensation can be altered with very high levels of neomycin eye drops.
  • The effects of topical paromomycin on the ocular surface have not been studied adequately. Frequent dosing and prolonged administration presumably can slow wound healing and may contribute to conjunctival hyperemia and punctate corneal erosions.
  • Topical diamidines can produce stinging and burning immediately after application. Conjunctival hyperemia and punctate corneal erosions have been attributed to its use.
  • Mast cell degranulation with histamine release is produced by propamidine. Contact hypersensitivity has been described.
  • While some corneal epithelial damage occurs with all topical anesthetics, it is most exaggerated when cocaine is used, with epithelial loosening and corneal erosions. This may be an advantage when removing epithelium in the treatment of a dendritic ulcer.
    • Toxic effects on epithelial cell metabolism and ultrastructure include depressed cellular respiration and glycolysis with lactic acid accumulation; alterations in desmosomes, intracellular mitochondria, rough endoplasmic reticulum, and tonofibrils; and inhibition of cell mitosis and migration.
    • Epithelial microvilli loss results in instability and rapid breakup of the tear film. Thus, local anesthetics may retard healing of corneal erosions as epithelial cells round up and accumulate at the wound margin. The epithelium may totally lift off the basement membrane proteins and cell membrane permeability; destruction of mitochondria, rough endoplasmic reticulum, and tonofibrils; and inhibition of cell mitosis and migration.

More on Corneal Erosion, Recurrent

Overview: Corneal Erosion, Recurrent
Differential Diagnoses & Workup: Corneal Erosion, Recurrent
Treatment & Medication: Corneal Erosion, Recurrent
Follow-up: Corneal Erosion, Recurrent
Multimedia: Corneal Erosion, Recurrent
References

References

  1. Laibson PR. Epithelial basement membrane dystrophy and recurrent erosions. In: Current Ocular Therapy. 5th ed. 2000:355-357.

  2. Lopez Bernal D, Ubels JL. Artificial tear composition and promotion of recovery of the damaged corneal epithelium. Cornea. Mar 1993;12(2):115-20. [Medline].

  3. Hykin PG, Foss AE, Pavesio C, Dart JK. The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye. 1994;8 (Pt 1):35-40. [Medline].

  4. Maréchal-Courtois C, Duchesne B. [Recurrent corneal erosion]. Bull Soc Belge Ophtalmol. 1993;247(1):13-5. [Medline].

  5. Gyldenkerne GJ, Ehlers N. [Excimer laser therapy of recurrent corneal erosions]. Ugeskr Laeger. Sep 12 1994;156(37):5282-4. [Medline].

  6. John ME, Van der Karr MA, Noblitt RL, Boleyn KL. Excimer laser phototherapeutic keratectomy for treatment of recurrent corneal erosion. J Cataract Refract Surg. Mar 1994;20(2):179-81. [Medline].

  7. Katz HR, Snyder ME, Green WR, Kaplan HJ, Abrams DA. Nd:YAG laser photo-induced adhesion of the corneal epithelium. Am J Ophthalmol. Nov 15 1994;118(5):612-22. [Medline].

  8. Rogers C, Cohen P, Lawless M. Phototherapeutic keratectomy for Reis Bucklers' corneal dystrophy. Aust N Z J Ophthalmol. Nov 1993;21(4):247-50. [Medline].

  9. Soong HK, Farjo Q, Meyer RF, Sugar A. Diamond burr superficial keratectomy for recurrent corneal erosions. Br J Ophthalmol. Mar 2002;86(3):296-8. [Medline].

  10. Aitken DA, Beirouty ZA, Lee WR. Ultrastructural study of the corneal epithelium in the recurrent erosion syndrome. Br J Ophthalmol. Mar 1995;79(3):282-9. [Medline].

  11. Arbour JD, Brunette I, Boisjoly HM, Shi ZH, Dumas J, Guertin MC. Should we patch corneal erosions?. Arch Ophthalmol. Mar 1997;115(3):313-7. [Medline].

  12. Baum JL. The Castroviejo Lecture. Prolonged eyelid closure is a risk to the cornea. Cornea. Nov 1997;16(6):602-11. [Medline].

  13. Ben Osman N, Jeddi A, Mtimet S, Marrakchi S, Ayed S. [Recurrent corneal erosion. Apropos of a case]. J Fr Ophtalmol. 1994;17(5):358-60. [Medline].

  14. Brennan NA, Coles ML. Extended wear in perspective. Optom Vis Sci. Aug 1997;74(8):609-23. [Medline].

  15. Brown N, Bron A. Recurrent erosion of the cornea. Br J Ophthalmol. Feb 1976;60(2):84-96. [Medline].

  16. Bruce AS, Brennan NA. Corneal pathophysiology with contact lens wear. Surv Ophthalmol. Jul-Aug 1990;35(1):25-58. [Medline].

  17. Buxton JN, Constad WH. Superficial epithelial keratectomy in the treatment of epithelial basement membrane dystrophy. Ann Ophthalmol. Mar 1987;19(3):92-6. [Medline].

  18. Campos M, Nielsen S, Szerenyi K, Garbus JJ, McDonnell PJ. Clinical follow-up of phototherapeutic keratectomy for treatment of corneal opacities. Am J Ophthalmol. Apr 15 1993;115(4):433-40. [Medline].

  19. Catania L. Primary Care of the Anterior Segment. 2nd ed. Norwalk, Conn: Appleton & Lange; 1994:237-241.

  20. Cavanaugh TB, Lind DM, Cutarelli PE, Mack RJ, Durrie DS, Hassanein KM, et al. Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy. Ophthalmology. May 1999;106(5):971-6. [Medline].

  21. Chandler PA. Recurrent erosion of the cornea. Am J Ophthalmol. 1945;28:355-367.

  22. Dausch D, Landesz M, Klein R, Schroder E. Phototherapeutic keratectomy in recurrent corneal epithelial erosion. Refract Corneal Surg. Nov-Dec 1993;9(6):419-24. [Medline].

  23. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. Jul 2001;132(1):8-13. [Medline].

  24. Forstot SL, Damiano RE, Witters R, et al. Diamond burr keratectomy for the treatment of recurrent corneal erosion syndrome. Ophthalmology (suppl). 1994;101:103.

  25. Foulks GN. Treatment of recurrent corneal erosion and corneal edema with topical osmotic colloidal solution. Ophthalmology. Aug 1981;88(8):801-3. [Medline].

  26. Friedman NJ, Kaiser PK, Trattler WB. Review of Ophthalmology. Elsevier Saunders; 221.

  27. Förster W, Grewe S, Atzler U, Lunecke C, Busse H. Phototherapeutic keratectomy in corneal diseases. Refract Corneal Surg. Mar-Apr 1993;9(2 Suppl):S85-90. [Medline].

  28. Galbavy EJ, Mobilia EF, Kenyon KR. Recurrent corneal erosions. Int Ophthalmol Clin. Summer 1984;24(2):107-31. [Medline].

  29. Geggel HS. Successful treatment of recurrent corneal erosion with Nd:YAG anterior stromal puncture. Am J Ophthalmol. Oct 15 1990;110(4):404-7. [Medline].

  30. Harkins T. The excimer laser and phototherapeutic keratectomy. Clin Eye Vis Care. 1995;7:103-6.

  31. Heyworth P, Morlet N, Rayner S, Hykin P, Dart J. Natural history of recurrent erosion syndrome--a 4 year review of 117 patients. Br J Ophthalmol. Jan 1998;82(1):26-8. [Medline].

  32. Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ, Jones HS. Oral tetracycline in the treatment of recurrent corneal erosions. Eye. 1994;8 (Pt 4):384-8. [Medline].

  33. Hsu JK, Rubinfeld RS, Barry P, Jester JV. Anterior stromal puncture. Immunohistochemical studies in human corneas. Arch Ophthalmol. Aug 1993;111(8):1057-63. [Medline].

  34. Ionides AC, Tuft SJ, Ferguson VM, Matheson MM, Hykin PG. Corneal infiltration after recurrent corneal epithelial erosion. Br J Ophthalmol. Jul 1997;81(7):537-40. [Medline].

  35. Kanski J. Clinical Ophthalmology. 3rd ed. London: Butterworths; 1994:135-6.

  36. Katsev DA, Kincaid MC, Fouraker BD, Dresner MS, Schanzlin DJ. Recurrent corneal erosion: pathology of corneal puncture. Cornea. Sep 1991;10(5):418-23. [Medline].

  37. Kenyon KR. Recurrent corneal erosion: pathogenesis and therapy. Int Ophthalmol Clin. Summer 1979;19(2):169-95. [Medline].

  38. Kremer I, Blumenthal M. Combined PRK and PTK in myopic patients with recurrent corneal erosion. Br J Ophthalmol. Jul 1997;81(7):551-4. [Medline].

  39. Laibson PR. Microcystic corneal dystrophy. Trans Am Ophthalmol Soc. 1976;74:488-531. [Medline].

  40. Lawless MA, Cohen P, Rogers C. Phototherapeutic keratectomy for Reis-Bückler's dystrophy. Refract Corneal Surg. Mar-Apr 1993;9(2 Suppl):S96-8. [Medline].

  41. Liu C, Buckley R. The role of the therapeutic contact lens in the management of recurrent corneal erosions: a review of treatment strategies. CLAO J. Jan 1996;22(1):79-82. [Medline].

  42. Mackie IA. Successful management of three consecutive cases of recurrent corneal erosion with botulinum toxin injections. Eye. Jul 2004;18(7):734-7. [Medline].

  43. Malecha MA. Anterior stromal puncture for recurrent corneal erosion after laser in situ keratomileusis. J Cataract Refract Surg. Feb 2004;30(2):496-8. [Medline].

  44. McDonnell PJ, Seiler T. Phototherapeutic keratectomy with excimer laser for Reis-Buckler's corneal dystrophy. Refract Corneal Surg. Jul-Aug 1992;8(4):306-10. [Medline].

  45. McGhee CN, Bryce IG, Anastas CN, Webber SK, Burvill M, Murray AT. Corneal topographic lagoons: a potential new marker for post-traumatic recurrent corneal erosion syndrome. Aust N Z J Ophthalmol. Feb 1996;24(1):27-31. [Medline].

  46. McLean EN, MacRae SM, Rich LF. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. Jun 1986;93(6):784-8. [Medline].

  47. Ramamurthi S, Rahman MQ, Dutton GN, Ramaesh K. Pathogenesis, clinical features and management of recurrent corneal erosions. Eye. Jun 2006;20(6):635-44. [Medline].

  48. Ramamurthi S, Ramaesh K. Anterior stromal puncture for recurrent corneal erosion after laser in situ keratomileusis. J Cataract Refract Surg. Jan 2005;31(1):9-10; author reply 10. [Medline].

  49. Rapuano CJ. Excimer laser phototherapeutic keratectomy: long-term results and practical considerations. Cornea. Mar 1997;16(2):151-7. [Medline].

  50. Reinhard T, Sundmacher R, Strunck-Kortenbusch B. [Corneal puncture in recurrent corneal erosion]. Ophthalmologe. Dec 1993;90(6):694-7. [Medline].

  51. Rhys C, Snyers B, Pirson Y. Recurrent corneal erosion associated with Alport's syndrome. Rapid communication. Kidney Int. Jul 1997;52(1):208-11. [Medline].

  52. Rodrigues MM, Laibson PR. Recurrent corneal erosions. Trans Pa Acad Ophthalmol Otolaryngol. Fall 1976;29(2):171-3. [Medline].

  53. Thygeson P. Observations on recurrent erosion of the cornea. Am J Ophthalmol. May 1959;47(5, Part 2):48-52. [Medline].

  54. Trobe JD, Laibson PR. Dystrophic changes in the anterior cornea. Arch Ophthalmol. Apr 1972;87(4):378-82. [Medline].

  55. Udell IJ, Ormerod LD, Boniuk V, Abelson MB. Treatment of contact lens-associated corneal erosions. Am J Ophthalmol. Sep 15 1987;104(3):306-7. [Medline].

  56. Waring GO 3rd, Rodrigues MM, Laibson PR. Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol. Sep-Oct 1978;23(2):71-122. [Medline].

  57. Wood TO. Recurrent erosion. Trans Am Ophthalmol Soc. 1984;82:850-98. [Medline].

Further Reading

Keywords

recurrent corneal erosion, RCE, recurrent corneal erosion syndrome, RCE syndrome, epithelial basement membrane dystrophy, map-dot-fingerprint dystrophy, microcystic corneal dystrophy, recurrent epithelial erosion, corneal abrasions, Cogan's microcystic corneal dystrophy, Cogan microcystic corneal dystrophy

Contributor Information and Disclosures

Author

Arun Verma, MD, Senior Consultant, Department of Ophthalmology, Dr Daljit Singh Eye Hospital, India
Disclosure: Nothing to disclose.

Coauthor(s)

Michael P Ehrenhaus, MD, Director, Department of Cornea, External Disease & Refractive Surgery, Assistant Professor, Department of Ophthalmology, State University of New York Downstate Medical Center
Michael P Ehrenhaus, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Institute
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.